What is Conflixis?
Founded in 2022, Conflixis provides an AI-powered platform specifically engineered for conflicts of interest (COI) management. The company addresses a significant pain point for hospitals and research organizations by replacing traditional, form-based disclosure methods with a dynamic, automated analysis engine. By synthesizing internal data with public records—including government payment databases and procurement logs—Conflixis identifies high-risk financial relationships between clinicians and industry partners. This proactive approach not only mitigates regulatory risk but also provides predictive spending insights, ensuring that procurement decisions remain transparent and ethically sound. The platform serves as a vital tool for organizations striving to maintain integrity while managing complex clinical and research programs.
How much funding has Conflixis raised?
Conflixis has raised a total of $4.5M across 2 funding rounds:
Other Financing Round
$275K
Angel/Seed
$4.2M
Other Financing Round (2024): $275K, investors not publicly disclosed
Angel/Seed (2024): $4.2M led by Lerer Hippeau Ventures, SpringTime Ventures, and Origin Ventures
Key Investors in Conflixis
Lerer Hippeau Ventures
A venture capital firm focused on early-stage investments, supporting founders who tackle challenging problems across both enterprise and consumer landscapes.
SpringTime Ventures
A seed-stage investment firm specializing in high-growth startups within the healthcare, fintech, and logistics sectors, emphasizing long-term founder relationships.
Origin Ventures
An early-stage venture capital firm that invests in bold founders and companies transforming productivity and automation through AI-native software.
What's next for Conflixis?
With this major enterprise-level funding, Conflixis is well-positioned to accelerate its product development and expand its footprint within the healthcare technology ecosystem. The strategic capital will likely be deployed to enhance the platform's predictive analytics capabilities and broaden its integration with existing enterprise resource planning systems. As healthcare organizations face mounting pressure to demonstrate transparency, Conflixis is poised to scale its operations, potentially setting a new industry standard for automated compliance and ethical procurement. The company's trajectory suggests a focus on deepening its market penetration among Tier-1 research institutions and large-scale hospital networks, where the cost of non-compliance remains a significant operational burden.
See full Conflixis company page
